Shortly after WAT Medical’s leading product to treat nausea-induced vomiting, EmeTerm, received its FDA clearance earlier in April, it has now also received official clearance from Health Canada. Health Canada
Vancouver BC – May 14, 2018 – WAT Medical’s leading product to treat nausea-induced vomiting, EmeTerm, has received its FDA clearance earlier in April. Now ready to officially enter the U.S.
On March 21,2018, it was a great honor to welcome Dr. Barry Burles，Dr. Paul Thomas and other members of the University of Cambridge who came to visit us. The University
Our future is being shaped by technology that’s evolving faster than we ever imagined. From AI machine learning to virtual and augmented reality, technology is revolutionizing every part of our
Cost Can be a Major Roadblock in Migraine Therapy The team from migraine.com conducted a survey in 2016 titled: “Migraine in America” with the goal to gain a better understanding
[vc_row][vc_column][vc_column_text]Morning sickness affects 70-80% of all pregnant women. About 60% of them experience nausea and vomiting. Morning sickness can decrease pregnant women’s work efficiency, result in unnecessary healthcare expenses, and